Cystic Fibrosis Clinical Trials Review 2024: Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status
September 27, 2024 06:55 ET
|
Research and Markets
Dublin, Sept. 27, 2024 (GLOBE NEWSWIRE) -- The "Cystic Fibrosis - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial report...
Cystic Fibrosis Therapeutics Research Report 2024: A Global $15.42 Billion Market by 2032 from $7.07 Billion in 2023 - Increase in R&D Investments and Legislation that is Supportive of the Industry
July 04, 2024 05:25 ET
|
Research and Markets
Dublin, July 04, 2024 (GLOBE NEWSWIRE) -- The "Cystic Fibrosis Therapeutics Market Report by Drug Class, Route of Administration, Distribution Channel, Regions and Company Analysis 2024-2032" report...
Cystic Fibrosis (CF) Therapeutics Global Market Research Report 2024: Burgeoning Emphasis on Personalized Medicine and Targeted Therapies - Long-term Forecasts to 2028 and 2033
June 27, 2024 07:40 ET
|
Research and Markets
Dublin, June 27, 2024 (GLOBE NEWSWIRE) -- The "Cystic Fibrosis (CF) Therapeutics Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The cystic fibrosis (cf)...
Cystic Fibrosis Therapeutics Global Strategic Business Report 2023-2030 Featuring Key Players - AbbVie, Galapagos, Genentech, Gilead Sciences, Novartis, and Vertex Pharmaceuticals
June 13, 2024 05:42 ET
|
Research and Markets
Dublin, June 13, 2024 (GLOBE NEWSWIRE) -- The "Cystic Fibrosis Therapeutics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
Cystic Fibrosis Market Pipeline Insights Report 2024 Featuring 75+ Companies and 80+ Pipeline Drugs, Including VX-121 (Vertex Pharma), Brensocatib (AstraZeneca), ELX-02 (Eloxx Pharma), and S-1226 (SolAeroMed)
April 16, 2024 09:16 ET
|
Research and Markets
Dublin, April 16, 2024 (GLOBE NEWSWIRE) -- The "Cystic Fibrosis - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
Global Cystic Fibrosis Lung Disease Market Forecasts Promising Growth with Advances in Therapeutics to 2029
January 08, 2024 13:08 ET
|
Research and Markets
Dublin, Jan. 08, 2024 (GLOBE NEWSWIRE) -- The "Global Cystic Fibrosis Lung Disease Market: Analysis By Drug Type, Route of Administration, Distribution Channel, By Region, By Country: Market...
Cystic Fibrosis (CF) Therapeutics Global Research Report 2023: Market to Reach $10.11 Billion in 2027 - Long-term Forecast to 2032
November 29, 2023 10:33 ET
|
Research and Markets
Dublin, Nov. 29, 2023 (GLOBE NEWSWIRE) -- The "Cystic Fibrosis (CF) Therapeutics Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global cystic fibrosis...
Global Cystic Fibrosis Therapeutics Markets, Trends, & Forecasts Report 2023-2028: Inhale Market will Capture Maximum Share of the $10+ Billion Market
March 03, 2023 04:58 ET
|
Research and Markets
Dublin, March 03, 2023 (GLOBE NEWSWIRE) -- The "Cystic Fibrosis Therapeutics Market, Size, Global Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Company Analysis" report has been...
Worldwide Industry for Cystic Fibrosis Therapeutics to 2025 - Players Include AbbVie, Alaxia and Alcresta Therapeutics Among Others
December 17, 2020 06:28 ET
|
Research and Markets
Dublin, Dec. 17, 2020 (GLOBE NEWSWIRE) -- The "Cystic Fibrosis Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to...